IBUPROFEN
- Product NDC
- 0363-9594
- 11-digit product format
- 003639594
- Labeler code
- 0363
- Product ID
- 0363-9594_46531382-aeef-ad11-e063-6294a90a81f4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- IBUPROFEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- WALGREENS CO.
- Application
- ANDA079174
- Marketing category
- ANDA
- Marketing start
- 2021-10-15
- Substance
- IBUPROFEN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- IBUPROFEN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IBUPROFEN | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WK2XYI10QM |
| Rxcui | 310965 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0363-9594-07 | IBUPROFEN | 15 in 1 BOTTLE | TABLET | 15 | | 7 |
| 0363-9594-10 | IBUPROFEN | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0363-9594 | IBUPROFEN TABLET [WALGREENS CO.] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241218_b8a77b7e-e161-b3ac-e053-2995a90af3e8.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0363-9594-07 | 00363959407 | 15 TABLET in 1 BOTTLE (0363-9594-07) | 15 tablet | 2023-09-01 | | No | No | Historical |
| 0363-9594-10 | 00363959410 | 100 TABLET in 1 BOTTLE (0363-9594-10) | 100 tablet | 2021-10-15 | 0000-00-00 | No | No | Current |